Literature DB >> 16597534

Current choices--good or bad--for the proactive management of postoperative ileus: A surgeon's view.

Theodore J Saclarides1.   

Abstract

Postoperative ileus (POI) is frequently experienced by many patients undergoing abdominal operations and other surgical procedures. Postoperative ileus causes physical discomfort and may increase risk for prolonged hospital length of stay. Despite its prevalence, there is currently no accepted standard definition of POI and, consequently, no standardized mode of prevention or treatment; it is no wonder that a variety of management approaches for POI have been developed. Some of these include alternative surgical techniques such as laparoscopic or endoscopic procedures to minimize trauma and help lessen the release of endogenous mediators of POI. Others have evaluated alternate analgesic regimens such as thoracic epidural anesthetics to avoid stimulating opioid receptors in the gut. These approaches have had varying results. Other pharmacologic attempts to reduce POI have focused on the blockade of opioid receptors to prevent opioid-induced GI-related adverse effects. A new class of agents, peripherally acting mu-opioid-receptor antagonists such as methylnaltrexone and alvimopan, may improve the pharmacologic management of POI and reshape the current paradigm of multimodal management of POI. Protocols that incorporate these agents may offer yet another avenue to mitigate the adverse effects of POI, and thus help improve surgical outcomes. To date, alvimopan has been shown in phase 3 clinical trials to significantly reduce the duration of POI while maintaining satisfactory analgesia and reducing length of hospital stay. Combinations of strategies with demonstrated effectiveness such as early feeding, epidural analgesia, laparoscopic surgery, and peripherally acting mu-opioid-receptor antagonists may help transform the management of POI into an effective multimodal paradigm that targets the diverse etiologic factors leading to this common clinical problem. Clearly, all surgical team members are crucial in the optimal implementation of such multimodal approaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597534     DOI: 10.1016/j.jopan.2006.01.008

Source DB:  PubMed          Journal:  J Perianesth Nurs        ISSN: 1089-9472            Impact factor:   1.084


  5 in total

1.  Alvimopan addition to a standard perioperative recovery pathway.

Authors:  Edward A Itawi; Lisa M Savoie; Amy J Hanna; George Y Apostolides
Journal:  JSLS       Date:  2011 Oct-Dec       Impact factor: 2.172

2.  Enhanced Recovery after Surgery Protocol Accelerates Recovery of Lumbar Disc Herniation among Elderly Patients Undergoing Discectomy via Promoting Gastrointestinal Function.

Authors:  Xiaohai Zuo; Linbang Wang; Longzhu He; Pei Li; Dandan Zhou; Yiping Yang
Journal:  Pain Res Manag       Date:  2021-11-22       Impact factor: 3.037

3.  Age Increases the Risk of Mortality by Four-Fold in Patients with Emergent Paralytic Ileus: Hospital Length of Stay, Sex, Frailty, and Time to Operation as Other Risk Factors.

Authors:  Guy Elgar; Parsa Smiley; Abbas Smiley; Cailan Feingold; Rifat Latifi
Journal:  Int J Environ Res Public Health       Date:  2022-08-11       Impact factor: 4.614

4.  Prevention of Paralytic Ileus Utilizing Alvimopan Following Spine Surgery.

Authors:  Kalpit N Shah; Gregory Waryasz; J Mason DePasse; Alan H Daniels
Journal:  Orthop Rev (Pavia)       Date:  2015-09-28

5.  Management of postoperative ileus after robot-assisted laparoscopic prostatectomy.

Authors:  Jee Soo Park; Jongchan Kim; Won Sik Jang; Ji Eun Heo; Ahmed Elghiaty; Koon Ho Rha; Young Deuk Choi; Won Sik Ham
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.